Effect of ABCG2 on cytotoxicity of platinum drugs: Interference of EGFP

被引:29
作者
Ceckova, Martina [1 ]
Vackova, Zuzana [1 ,2 ]
Radilova, Hana [2 ]
Libra, Antonin [2 ]
Buncek, Martin [2 ]
Staud, Frantisek [1 ]
机构
[1] Charles Univ Prague, Dept Pharmacol & Toxicol, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic
[2] Generi Biotech sro, Hradec Kralove, Czech Republic
关键词
Platinum cytostatics; ABCG2; MTT assay; Neutral red assay; Cytotoxicity; Apoptosis; EGFP;
D O I
10.1016/j.tiv.2008.09.001
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
ATP-binding drug efflux transporters decrease intracellular concentrations of cytotoxic drugs, causing multidrug resistance in cancer. In this study, we examined possible interactions of ABCG2 transporter with platinum cytotoxic drugs. We demonstrate here an interference of platinum drugs with enhanced green fluorescence protein (EGFP) in the cellular models, where EGFP was employed as a reporter gene. Cytotoxicity of cisplatin (CIP), carboplatin (CAP) and oxaliplatin (OXP) was significantly lowered in MDCKII cells transfected with ABCG2 transporter and EGFP reporter. The IC50 values in MDCKII-ABCG2 were 25.7, 164 and 165 mu M for CIP, CAP and OXP, respectively, whereas IC50 for the same cytostatics in MDCKII cells were as follows: 15.4, 133 and 50.3 mu N. Addition of fumitremorgin C (FTC), a potent ABCG2 inhibitor, significantly suppressed the resistance of MDCKII-ABCG2 to OXP, suggesting that OXP interacts with ABCG2. However, FTC did not change the sensitivity of the cells to CIP and CAP. We assume that EGFP rather than ABCG2 causes the diminished toxicity of the platinum cytostatics in the transfected cells. This hypothesis was confirmed in human Hep2 cells expressing EGFP: using MTT test, IC50 of 30.0, 247 and 27.9 mu M were obtained for CIP, CAP and OXP, respectively, while 12.3, 106 and 20.5 mu M were observed in the parent Hep2 cells. Employing neutral red cytotoxicity assay, similar data were obtained (IC50 7.73, 685 and 112 mu M for CIP, CAP, and OXP. respectively, in the Hep2-EGFP cells and 1.65, 79.4 and 24.5 mu M in the parent Hep2 cells). Caspase-3/7 assay revealed lower susceptibility of EGFP expressing Hep2 cells to apoptosis induced by CIP when compared to the parent cell line. We therefore conclude that EGFP in transfected cells interferes with cytotoxicity of platinum drugs by hindering the drug induced apoptosis and could cause misinterpretation of results obtained in cytotoxicity studies. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1846 / 1852
页数:7
相关论文
共 43 条
[11]   Cell damage and reactive oxygen species production induced by fluorescence microscopy: effect on mitosis and guidelines for non-invasive fluorescence microscopy [J].
Dixit, R ;
Cyr, R .
PLANT JOURNAL, 2003, 36 (02) :280-290
[12]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[13]   Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens [J].
Enokizono, Junichi ;
Kusuhara, Hiroyuki ;
Sugiyama, Yuichi .
MOLECULAR PHARMACOLOGY, 2007, 72 (04) :967-975
[14]   Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA [J].
Evers, R ;
Kool, M ;
van Deemter, L ;
Janssen, H ;
Calafat, J ;
Oomen, LCJM ;
Paulusma, CC ;
Elferink, RPJO ;
Baas, F ;
Schinkel, AH ;
Borsi, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1310-1319
[15]   INTRACELLULAR SUPRAVITAL STAIN DELOCALIZATION AS AN ASSAY FOR ANTIBODY-DEPENDENT COMPLEMENT-MEDIATED CELL DAMAGE [J].
FILMAN, DJ ;
BRAWN, RJ ;
DANDLIKER, WB .
JOURNAL OF IMMUNOLOGICAL METHODS, 1975, 6 (03) :189-207
[16]   The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy [J].
Hall, Matthew D. ;
Okabe, Mitsunorl ;
Shen, Ding-Wu ;
Liang, Xing-Jie ;
Gottesman, Michael M. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2008, 48 :495-535
[17]   Cholesterol conjugated oligonucleotide and LNA:: A comparison of cellular and nuclear uptake by Hep2 cells enhanced by Streptolysin-O [J].
Holasová, S ;
Mojzísek, M ;
Buncek, M ;
Vokurková, D ;
Radilová, H ;
Safárová, M ;
Cervinka, M ;
Haluza, R .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 276 (1-2) :61-69
[18]   Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan [J].
Jonker, JW ;
Smit, JW ;
Brinkhuis, RF ;
Maliepaard, M ;
Beijnen, JH ;
Schellens, JHM ;
Schinkel, AH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) :1651-1656
[19]   Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2 [J].
Kowalski, P ;
Stein, U ;
Scheffer, GL ;
Lage, H .
CANCER GENE THERAPY, 2002, 9 (07) :579-586
[20]  
Kuo MT, 2007, ADV EXP MED BIOL, V608, P23